Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma.
Autor: | Socinski, Mark A., Sandler, Alan B., Israel, Valerie K., Gillenwater, Heidi H., Miller, Langdon L., Locker, Paula K., Antonellini, Alessandro, Elfring, Gary L., Natale, Ronald B. |
---|---|
Zdroj: | Cancer (0008543X); Oct2002, Vol. 95 Issue 7, p1520-1527, 8p |
Databáze: | Complementary Index |
Externí odkaz: |